83 filings
Page 2 of 5
8-K
rh1nkdt3yyr7vstwt
16 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:08pm
8-K
obivwo
11 May 23
Nuvalent Announces Anticipated Timing of Preliminary Phase 1 Dose-Escalation Data for NVL-655 and Reports First Quarter 2023 Financial Results
6:39am
ARS
6z0d9k w24p
28 Apr 23
Annual report to shareholders
4:17pm
DEFA14A
x9z5z2ew
28 Apr 23
Additional proxy soliciting materials
12:00am
PRE 14A
xa459sp1124nvxif
13 Apr 23
Preliminary proxy
4:30pm
S-8
sttld48j sw
16 Mar 23
Registration of securities for employees
7:36am
S-3ASR
vfu5fv7a4k rbhn7
16 Mar 23
Automatic shelf registration
7:29am
8-K
6b893u7g
16 Mar 23
Nuvalent Highlights Pipeline and Business Progress and Reports Fourth Quarter and Full Year 2022 Financial Results
6:36am
8-K
301g2tz
10 Mar 23
Regulation FD Disclosure
8:38pm
8-K
3qft90 t9yn9yts2bso2
10 Nov 22
Nuvalent Reviews Corporate and Pipeline Achievements and Reports Third Quarter 2022 Financial Results
6:37am
8-K
xr8d6mauswxo
1 Nov 22
Nuvalent Announces Pricing of Public Offering of Common Stock
5:19pm
424B5
iwc g0nguuu7xrzx8
1 Nov 22
Prospectus supplement for primary offering
5:17pm
424B5
vtq7y zo68hpmok
1 Nov 22
Prospectus supplement for primary offering
5:16pm
424B5
1bpjjq87ph3 ei
31 Oct 22
Prospectus supplement for primary offering
7:21am
8-K
zg6 aodzqkwdd
28 Oct 22
Other Events
6:05am
8-K
m9noi850js 0s8jx
6 Oct 22
Departure of Directors or Certain Officers
4:16pm